BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2635616)

  • 1. Tumor-associated tissue eosinophilia in the urinary bladder: is it a real relationship?
    Dworák O; Janssen D
    Appl Pathol; 1989; 7(5):294-7. PubMed ID: 2635616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder.
    Darvishian F; Teichberg S; Meyersfield S; Urmacher CD
    Ann Clin Lab Sci; 2001 Apr; 31(2):147-50. PubMed ID: 11337903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of multiple mucosal biopsies in new cases of superficial papillary bladder tumor].
    Kanamaru H; Shirahase T; Moroi S; Taniguchi T; Kuo JY; Okuno H; Kihara Y; Arai Y
    Hinyokika Kiyo; 1993 Feb; 39(2):127-30. PubMed ID: 8465685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and morphology of coexisting carcinomas of the urinary bladder and prostate].
    Weidhase A; Kunze E
    Verh Dtsch Ges Pathol; 1993; 77():142-6. PubMed ID: 7511273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The systematic histologic elaboration of urinary bladders with different pathologic findings (urinary bladder carcinoma, tumor-free aging urinary bladders)].
    Theuring U; Theuring F
    Gegenbaurs Morphol Jahrb; 1989; 135(1):203-6. PubMed ID: 2737420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypereosinophilia associated with transitional cell carcinoma in a cat.
    Sellon RK; Rottman JB; Jordan HL; Wells MR; Simpson RM; Nelson P; Keene BW
    J Am Vet Med Assoc; 1992 Aug; 201(4):591-3. PubMed ID: 1517134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, staging, and classification of bladder tumors.
    Cummings KB
    Semin Urol; 1983 Feb; 1(1):7-14. PubMed ID: 6679097
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathology of bilharzial bladder cancer.
    Godwin JT; Hanash K
    Prog Clin Biol Res; 1984; 162A():95-143. PubMed ID: 6483922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature.
    Sanborn SL; MacLennan G; Cooney MM; Zhou M; Ponsky LE
    Urology; 2009 Apr; 73(4):928.e13-5. PubMed ID: 19056107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated tissue eosinophilia and inflammation in pTa and pT1 papillary urothelial carcinoma of the bladder.
    Marusić Z; Cupić H; Kruslin B; Tomas D; Milosević M; Mikuz G
    Anal Quant Cytol Histol; 2009 Aug; 31(4):239-41. PubMed ID: 19736872
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intracavitary methylene blue dye in the diagnosis of dysplasias and tumors of the urinary bladder].
    Richter A; Klatte D; Boran R
    Z Urol Nephrol; 1987 May; 80(5):263-5. PubMed ID: 3617954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.
    Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S
    Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM; Leav I; Kwan PW; Russell P; Merk FB
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.